References
- ThapaRPaudyalGBernsteinPSDemographic characteristics, patterns, and risk factors for retinal vein occlusion in Nepal: a hospital-based case-control studyClinic Experiment Ophthalmol2010386583590
- LimLLCheungNWangJJPrevalence and risk factors of retinal vein occlusion in an Asian populationBr J Ophthalmol200892101316131918684751
- KleinRKleinBEMossSEMeuerSMThe epidemiology of retinal vein occlusion: The Beaver Dam Eye StudyTrans Am Ophthalmol Soc20099813314111190017
- The Branch Vein Occlusion Study GroupArgon laser photocoagulation for macular edema in branch vein occlusionAm J Ophthalmol19849832712826383055
- HouJTaoYJiangYRLiXXGaoLIntravitreal bevacizumab versus triamcinolone acetonide for macular edema due to branch retinal vein occlusion: a matched studyChin Med J (Engl)2009122222695269919951598
- IpMSGottliebJLKahanaAIntravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusionArch Ophthalmol200412281131113615302652
- NomaHMinamotoAFunatsuHIntravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusionGraefes Arch Clin Exp Ophthalmol2006244330931516133018
- RosenfeldPHFungAEPuliafitoCAOptical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for macular edema from central vein occlusionOphthalmic Surg Lasers Imaging200536433633916156153
- RabenaMDPieramiciDJCastellarinAANasirMAAveryRLIntravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusionRetina200727441942517420692
- PragerFMichelsSKriechbaumKIntravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trialBr J Ophthalmol200993445245619074916
- DemirMObaEGulkilikGOdabasiMOzdalEIntravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month resultsClin Ophthalmol2011574574921750607
- AhmadiAAChuoJYBanashkevichAMaPEMaberleyDAThe effects of intravitreal bevacizumab on patients with macular edema secondary to branch retinal vein occlusionCan J Ophthalmol200944215415919491948
- GutièrrezJCBarquetLACaminalJMIntravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusionClin Ophthalmol20082478779119668432
- AbeggMTappeinerCWolf-SchnurrbuschUBarthelmesDWolfSFleischhauerJTreatment of branch retinal vein occlusion induced macular edema with bevacizumabBMC Ophthalmol200881818823536
- FigueroaMSContrerasINovalCSArruabarrenaCResults of bevacizumab as the primary treatment for retinal vein occlusionsBr J Ophthalmol20109481052105620679089
- KriechbaumKMichelsSPragerFIntravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective studyBr J Ophthalmol200892451852218211942